Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

作者：Adeola Adeyeye, Beatriz Grinsztejn, Mark A. Marzinke, Brett Hanscom, Alex R. Rinehart, Susan H. Eshleman, Julie Franks, Javier Valencia, Marybeth McCauley, Yashna Singh, Taimur Khan, HPTN study group, Kailazarid Gomez Feliciano, Myron S. Cohen, Deborah Donnell, Naiymah Sanchez, Paul A. Richardson, Susan L. Ford, Philip A. Sullivan, Andrea Jennings, Bernardo Maia, Keren Middelkoop, Raphael J. Landovitz, Steven A. Safren, Emília M. Jalil, Jonathan Lucas, Christina Psaros, James F. Rooney, Carolina Coutinho, Nadir Cardozo, Zhe Wang · 发表于：UNC Libraries · 年份：2025 · DOI：10.17615/9zee-gb05 · 研究领域：HIV/AIDS Research and Interventions、HIV/AIDS drug development and treatment、HIV Research and Treatment